Yan, Allison
Gallardo, Matthew
Savu, Andrei
Kaffenberger, Benjamin
Funding for this research was provided by:
College of Medicine Office of Research, Ohio State University
Article History
Received: 21 November 2023
Revised: 26 April 2024
Accepted: 27 April 2024
First Online: 15 June 2024
Declarations
:
: Dr. Kaffenberger has received grants from InflaRx, consulting fees from Eli Lilly and Novartis, and payment for expert testimony related to pyoderma gangrenosum. Ms. Yan, Mr. Gallardo, and Mr. Savu have no conflicts of interest to disclose.
: This project was approved by the Ohio State University Wexner Medical Center IRB.